Page 260 - fbkCardioDiabetes_2017
P. 260

236                      Cardio Diabetes Medicine 2017





                                                                 Advantages:
                                                                 1.   Inexpensive.

                                                                 2.  Can be done from standard lipid profile.
                                                                 3.  Should be in Non Fasting state.

                                                                 Atherogensity of elevated RLP s:
                                                                 Elevated remnant  lipoprotein-cholesterol  like  LDL
                                                                 Cholesterol  enter and is  trapped  in the arterial  wall
                                                                 leading  to accumulation  of  intimal Cholesterol  and
                                                                 progressive vascular injury.

                                                                   Also,  they are  associated with lowgrade  inflamma-
                                                                 tory reactions like endothelial Dysfunction ,impaired
                                                                 vasodilatation. Leading to thrombus formation.

                                                                 CAUSES:

                                                                 Obesity
                                                                 Poorly controlled DM
                                                                 Alcoholic excess
                                                                 High estrogen  Endogenous
                                                                               ↓
                                                                               Exogenous

                                                                 Drugs –Steroids oral contraceptives.
                                                                 Genetic variants
                                                                               ↓
                                                                        COMMON        -------→       RARE

                                                                               ↓
                                                                 Combination  of multiple factors Chylomicronemia
                                                                 Syndrome

                                                                 Like Obesity | DM | High estrogen
                                                                 Evidence Based:3

              Measurement of RLP s:1                             MAJOR TRIALS FOR RLP ----→  ↑RESIDUAL
              Limitations:                                       RISK:
              •  Remnant Lipoproteins are different both in compo-  RLPs  contribute to atherogenesis  was first  made by
                sition of lipids  and apolipoproteins  as a result  of   Zilversmit in 1979.
                different stages of lipolysis at the time of study .
                                                                 •  Framingham Off spring study Serum levels of RLP
              •  -Formed by two different pathways .               correlate well with the risk of events in women with
                                                                   established CAD.
              •  -So very difficult to measure them precisely.
                                                                 •  Honolulu heart study :Serum levels of RLP correlat-
              Alternatively :
                                                                   ed well with CV events of asian men.
              Non Fasting Remnant  Lipoprotein  Cholesterol=Total
              Cholesterol –HDL-c –LDL-cholesterol.               •  ACCORD  trial  –RLP  level  correlated  well  with the
                                                                   CV risks  in diabetic women in post  prandial  sub-
                                                                   study.


                                                         GCDC 2017
   255   256   257   258   259   260   261   262   263   264   265